Article ID Journal Published Year Pages File Type
6048596 Burns 2015 12 Pages PDF
Abstract
Large variation exists in the ability of AMD to prevent biofilm formation and colonisation of wounds. A standardised in vitro methodology should be developed for external parties to examine and compare the efficacies of commercially available AMDs, along with robust clinical randomised controlled trials. This is essential for informed clinical decision-making and optimal patient management.
Related Topics
Health Sciences Medicine and Dentistry Critical Care and Intensive Care Medicine
Authors
, , , , , , , , , ,